Autoimmunity and immunosuppression.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 1902124)

Published in Proc R Soc Med on November 01, 1967

Authors

M C Berenbaum

Articles cited by this

The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type. J Exp Med (1961) 6.05

The role of macrophages in the induction of antibody in x-irradiated animals. Immunology (1967) 5.36

Central and peripheral effects of anti-lymphocyte sera. Lancet (1967) 3.76

In vitro studies of ulcerative colitis. II. Cytotoxic action of white blood cells from patients on human fetal colon cells. J Exp Med (1963) 2.95

Effect of 6-mercaptopurine on inflammation. Am J Pathol (1962) 2.07

QUANTITATIVE STUDIES ON THE BEHAVIOR OF SENSITIZED LYMPHOCYTES IN VITRO. II. INHIBITORY INFLUENCE OF THE IMMUNE SUPPRESSOR, IMURAN, ON THE DESTRUCTIVE REACTION OF SENSITIZED LYMPHOID CELLS AGAINST HOMOLOGOUS TARGET CELLS. J Exp Med (1965) 1.98

Treatment of adjuvant arthritis in rats with anti-inflammatory drugs. Arthritis Rheum (1966) 1.88

INHIBITION OF IMMEDIATE AND DELAYED HYPERSENSITIVITY IN THE RABBIT BY 6-MERCAPTOPURINE. J Immunol (1964) 1.85

STUDIES ON ADJUVANT-INDUCED POLYARTHRITIS IN RATS. 3. THE EFFECT OF "IMMUNOSUPPRESSIVE AGENTS" ON ARTHRITIS AND TUBERCULIN HYPERSENSITIVITY. Arthritis Rheum (1964) 1.78

Homograft target cells: contact destruction in vitro by immune macrophages. Science (1966) 1.77

The inhibitory effect of hydrocortisone on lysis of homologous cells by lymphocytes in vitro. J Immunol (1962) 1.64

Early experiences with azathioprine in ulcerative colitis; a note of caution. JAMA (1966) 1.50

Destruction of human cells in tissue culture by lymphocytes from patients with systemic lupus erythematosus. Lancet (1966) 1.43

THE EFFECT OF 6-MERCAPTOPURINE ON IMMUNE RESPONSE IN MAN. N Engl J Med (1964) 1.35

Studies on the radiosensitive phase of the primary antibody response in rabbits. I. The role of the macrophage. J Immunol (1967) 1.24

EFFECT OF MONONUCLEAR BLOOD CELLS FROM MULTIPLE SCLEROSIS PATIENTS ON NEUROGLIA IN TISSUE CULTURE. J Neuropathol Exp Neurol (1964) 1.23

STUDIES ON THE LYMPHOCYTE RESPONSE TO INFLAMMATION. Ann N Y Acad Sci (1964) 1.17

Inhibition of the local inflammatory response in man by antimetabolites. Blood (1966) 1.03

Steroids and serum complement in mice: influence of hydrocortisone, diethylstilbestrol, and testosterone. Science (1966) 1.02

EFFECTS OF SELECTED CYTOTOXIC AGENTS ON ANTIBODY PRODUCTION IN MAN; A PRELIMARY REPORT. Ann N Y Acad Sci (1964) 0.94

Inhibition of the primary immune response in man by anti-metabolites. Cancer Res (1965) 0.93

The present status of treatment of autoimmune hemolytic anemia with ACTH and cortisone. Blood (1956) 0.92

Dermatologic clinics. 2. Antimalarial drugs in the therapy of lupus erythematosus. Proc Staff Meet Mayo Clin (1962) 0.87

IMMUNOLOGIC RESPONSES OF HEALTHY VOLUNTEERS RECEIVING AZATHIOPRINE (IMURAN). Int Arch Allergy Appl Immunol (1965) 0.87

STUDIES ON THE EFFECT OF CORTISOL AND CORTICOTROPHIN ON INCORPORATION OF ADENINE-8-14-C INTO THE LYMPHATIC TISSUE NUCLEIC ACIDS. Acta Endocrinol (Copenh) (1965) 0.84

[EFFECT OF EPSILON-AMINOCAPROIC ACID ON EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS]. Experientia (1963) 0.82

Antibody response to influenza-virus vaccine in children with nephrosis: effect of cortisone. Pediatrics (1959) 0.81

The influence of cortisone and hydrocortisone on the production of circulating antibody in human beings. J Allergy (1953) 0.80

Chloroquine: its mechanism of action upon immune phenomena. Arch Dermatol (1965) 0.77

Comparative effects of aspirin, ACTH, and cortisone on the antistreptolysin O titer and gamma globulin concentration in rheumatic fever. J Lab Clin Med (1954) 0.77

Cortisol in the regulation of RNA and protein synthesis. Nature (1967) 0.77

Articles by these authors

A method for testing for synergy with any number of agents. J Infect Dis (1978) 9.52

Is azathioprine a better immunosuppressive than 6-mercaptopurine? Clin Exp Immunol (1971) 3.47

Synergy, additivism and antagonism in immunosuppression. A critical review. Clin Exp Immunol (1977) 2.89

Postoperative depression of the lymphocyte response to phytohaemagglutinin. Lancet (1967) 2.57

Criteria for analyzing interactions between biologically active agents. Adv Cancer Res (1981) 2.49

The expected effect of a combination of agents: the general solution. J Theor Biol (1985) 2.06

In vivo biological activity of the components of haematoporphyrin derivative. Br J Cancer (1982) 1.82

Photodynamic destruction of human bladder carcinoma. Br J Cancer (1975) 1.55

Cerebral photosensitisation by haematoporphyrin derivative. Evidence for an endothelial site of action. Br J Cancer (1986) 1.53

Time-dependent immunosuppressive effects of anti-thymocyte serum. Nature (1967) 1.48

meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. Br J Cancer (1986) 1.47

Dose-response curves for agents that impair cell reproductive integrity. A fundamental difference between dose-response curves of antimetabolites and those for radiation and alkylating agents. Br J Cancer (1969) 1.44

Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Br J Cancer (1991) 1.42

Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide. Cancer Res (1974) 1.36

Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol (1973) 1.29

Correlations between methods for measurement of synergy. J Infect Dis (1980) 1.29

The growth of human tumours in immunosuppressed mice and their response to chemotherapy. Br J Cancer (1974) 1.27

In vivo determination of the fractional kill of human tumor cells by chemotherapeutic agents. Cancer Chemother Rep (1972) 1.26

Cell respiration as a requirement for antibody release in vitro. Nature (1968) 1.21

Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. Biochem J (1989) 1.19

Synergistic effect of cortisol and prostaglandin E2 on the PHA response. Relation to immunosuppression induced by trauma. Clin Exp Immunol (1976) 1.11

The therapeutic significance of the dose response curve for antilymphocytic serum. Transplantation (1971) 1.02

The effect of microsomal enzyme inhibition on the immunosuppressive and toxic effects of cyclophosphamide. Clin Exp Immunol (1973) 1.01

Immunosuppression by L-asparaginase. Nature (1970) 0.99

The relation between the physico-chemical properties and immunosuppressive effects of an homologous series of sulphonic acid esters. Immunology (1967) 0.97

Effects of L-asparaginase on lymphocyte-target cell reactions in vitro. Nature (1970) 0.95

Synergy with double and triple antibiotic combinations compared. J Antimicrob Chemother (1983) 0.95

The sensitivity to chemotherapeutic agents of a rat tumour grown in immunosuppressed mice. Br J Cancer (1971) 0.95

Wavelength and light-dose dependence in tumour phototherapy with haematoporphyrin derivative. Br J Cancer (1985) 0.94

Immunosuppressive agents: the design of selective therapeutic schedules. Antibiot Chemother (1969) 0.93

The rabbit VX2 tumour as a model for carcinomas of the tongue and larynx. Acta Otolaryngol (1989) 0.91

Synergy assessment with growth curves. J Infect Dis (1984) 0.90

Radiosensitivity of immunologically activated cells. Nature (1966) 0.89

Minor synergy and antagonism may be clinically important. J Antimicrob Chemother (1987) 0.88

Selective suppression of murine antibody-dependent cell-mediated cytotoxicity by azathioprine. Transplantation (1975) 0.87

HPD - a study of its components and their properties. Adv Exp Med Biol (1983) 0.87

The localization of haemolytic antibody in sections of lymphoid organs: an improved method. Immunology (1970) 0.84

Synergy and antagonism are not synonymous with therapeutic advantage and disadvantage. J Antimicrob Chemother (1988) 0.84

Role of mitosis and mitotic inhibition in the immunosuppressive action of thioguanine. Nature (1966) 0.83

Consequences of synergy between environmental carcinogens. Environ Res (1985) 0.82

The effect of cysteine on the immunosuppressive activity of busulphan, cyclophosphamide and nitrogen mustard. Br J Cancer (1971) 0.82

Protective effects of a novel perfluorochemical emulsion in photodynamic therapy. Biomater Artif Cells Immobilization Biotechnol (1992) 0.82

Time-dependence and selectivity of immunosuppressive agents. Immunology (1979) 0.82

Transplantation and immunosuppression. Mod Trends Immunol (1967) 0.81

Effect of some metabolic inhibitors on plaque formation in Jerne plates. Nature (1967) 0.81

Effect of cyclophosphamide on the homograft response in the guinea pig. Transplantation (1965) 0.81

Re: W. R. Greco et al., Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. Cancer Res., 50: 5318-5327, 1990. Cancer Res (1992) 0.81

The mode of action of cytotoxic drugs. Proc R Soc Med (1970) 0.80

Differential asparaginase sensitivity of T-cell and B-cell responses. Clin Exp Immunol (1973) 0.80

Porphyrin sensitizers in tumour phototherapy. Novel sensitizers of the chlorin and bacteriochlorin class with amphiphilic properties. J Photochem Photobiol B (1990) 0.79

Research ethics and deception. Lancet (1980) 0.78

Letter: Predicting response of human cancer to chemotherapy. Lancet (1974) 0.78

Immunosuppressive agents: generation and consequences of differing dose-response curves. Proc R Soc Med (1972) 0.78

Intercellular immunological controls and modulation of cyclic AMP levels. Some doubts. Immunology (1976) 0.77

Neutrophil function during chemotherapy for Hodgkin's disease. Br J Cancer (1981) 0.77

Photodynamic therapy of a mouse glioma: intracranial tumours are resistant while subcutaneous tumours are sensitive. Br J Cancer (1991) 0.77

Immunosuppression by platinum diamines. Br J Cancer (1971) 0.77

Increased therapeutic efficiency of a lipid-soluble alkylating agent incorporated in liposomes. Br J Cancer (1982) 0.75

Concepts for describing the interaction of two agents. Radiat Res (1991) 0.75

Modes of action of immunosuppressive agents. Proc R Soc Med (1967) 0.75

Dose-response curves for agents that impair cell reproductive integrity. The relation between dose-response curves and the design of selective regimens in cancer chemotherapy. Br J Cancer (1969) 0.75

The last surviving cancer cell: the chances of killing it. Cancer Chemother Rep (1968) 0.75

The immunosuppressive effects of 5-fluorocytosine and 5-fluorouracil. Chemotherapy (1979) 0.75

Intrathecal interferon, indomethacin, and multiple sclerosis. Lancet (1987) 0.75

Antagonism between radiosensitizing agents. Br J Radiol (1988) 0.75

Effect of L-asparaginase on germinal centre haemolysin. Nature (1971) 0.75

Subcutaneous Corynebacterium parvum in bladder cancer: a controlled study of its immunological effects. Br J Urol (1979) 0.75

Muscle damage and recovery in the rabbit tongue following photodynamic therapy with haematoporphyrin derivative. Acta Otolaryngol (1991) 0.75

Growth of human and rat tumours in immunosuppressed mice. J Pathol (1972) 0.75

Anti-HIV synergy between dextran sulphate and zidovudine. Lancet (1987) 0.75